That's why Queller says that you should look for the following (and it's even better when they're used in combination)
Compounding involves creating a medication tailored to an individual patients needs, typically when a commercially available drug doesnt meet those needs
That's the published pharmacokinetic profile of every macromolecule we discuss in this guide
Cues conditioned to withdrawal and negative reinforcement: Neglected but key motivational elements driving opioid addiction
DSC-based analysis of the C-terminal domain of chicken gizzard caldesmon CaD, (CaD 136 , residues 636771) and series of its single tryptophan mutants (W674A, W707A, and W737A) and a double tryptophan mutant (W674A/W707A) revealed that all these proteins are characterized by high specific heat capacity values (ranging from 23 J/(g K)) and the absence of distinct heat absorption peaks within the temperature region from 10 to 100 C suggested that their structure is predominantly unfolded (Permyakov et al., 2015)
If better means a peptide some patients ask for because they want to avoid strong appetite effects, or they want something they believe targets fat loss more directly, then AOD 9604 can show up as an interest point